SAN CARLOS, Calif. and WASHINGTON – GO2 for Lung Cancer (GO2 for Lung Cancer) announced its leadership in the launch of an important multi-institutional study to determine how to improve the participation of Black communities in lung cancer clinical [...]
Addario Lung Cancer Medical Institute and GO2 for Lung Cancer to learn about environmental, lifestyle, and demographic risks of developing lung cancer under the age of 40 San Carlos, CA/Washington DC – Continuing their collaboration to transform lung cancer [...]
SAN CARLOS, Calif. and WASHINGTON, D.C., November 14, 2020 – GO2 for Lung Cancer (GO2 for Lung Cancer) will honor leaders in lung cancer research and treatment, as well as dedicated lung cancer caregivers, at its Simply the Best [...]
SAN CARLOS, Calif. and WASHINGTON, Oct. 22, 2020 /PRNewswire/ -- GO2 for Lung Cancer announced it will celebrate Genentech with the "Simply the Best Award" at its XV Virtual Annual Simply the Best Gala on November 14, 2020 at 6:30 pm PT. Genentech will be honored for its continued [...]
SAN CARLOS, Calif. and WASHINGTON, Oct. 21, 2020 /PRNewswire/ -- GO2 for Lung Cancer is pleased to announce that Christine Lovly, MD, PhD, has been named as the incoming chair of GO2 Foundation's Scientific Leadership Board (SLB). Dr. Lovly, an associate professor of Medicine, Ingram [...]
We are pleased to announce that GO2 for Lung Cancer is part of a recently-awarded five-year grant from the National Cancer Institute as part of its new SeroNet initiative. This project seeks to uncover whether people with lung cancer, [...]
Congratulations to our own Bonnie J. Addario for receiving the Lifetime Achievement Award from Cure Magazine. We are so proud! Bonnie’s awe-inspiring message of empowerment has reached millions. CRANBURY, N.J.--(BUSINESS WIRE)--CURE Media Group, the industry-leading multimedia platform devoted to [...]
On August 7th, 2020, the Food and Drug Administration (FDA) approved the Guardant 360 CDx for comprehensive biomarker testing for patients with any solid tumor. The FDA based their approval on data from the clinical trials FLAURA and AURA3 [...]
GO2 for Lung Cancer recognizes Professor Swanton for genetic research transforming lung cancer treatment San Carlos, CA and Washington, D.C., July 23, 2020 – GO2 for Lung Cancer (GO2 for Lung Cancer) will present Charles Swanton, M.D., Ph.D., FRCP, [...]
WASHINGTON, June 23, 2020 /PRNewswire/ -- The Lung Cancer Registry has launched a landmark new survey on the impact of lung treatments on women's sexual health. The aim is to explore the magnitude of the problem and give researchers and clinicians new insights [...]